Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial

Objectives Persons at high risk of rheumatoid arthritis (RA) might benefit from a low-risk pharmacological intervention aimed at primary prevention. Previous studies demonstrated disease-modifying effects of statins in patients with RA as well as an association between statin use and a decreased ris...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maarten Boers, Michael T Nurmohamed, Calin D Popa, Dirkjan van Schaardenburg, Marian van Beers-Tas, Laurette van Boheemen, Samina Turk, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Alper van Sijl
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2021-02-01
coleção:	RMD Open
Acesso em linha:	https://rmdopen.bmj.com/content/7/1/e001591.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!